Centre for Antibiotic Allergy and Research
Department of Infectious Diseases and Immunology, Austin Health - 145 Studley Road Heidelberg, Melbourne, VIC 3084, Australia
@CAAR_Aus | +61394964572
National Antibiotic Allergy Network
KEY INFORMATION
NAAN Purpose:
The National Antibiotic Allergy Network (NAAN) is a collaborative group of mixed discipline clinicians and policy makers related to antibiotic allergy. The NAAN Steering Committee has representatives from each state and territory representing AMS activities. The Committee has further representation from key allergy and AMS clinicians, societies, and research centres. The NAAN committee reports to the AMS Jurisdiction Network.
Key Objectives:
The NAAN provides a repository of consumer and clinician antibiotic allergy protocols, policies and procedures, that can be disseminated and implemented nationally, in particular to aid sites with limited resources or experience with antibiotic allergy.
The NAAN Committee and its members will be a resource for support for health services in the establishment and implementation of antibiotic allergy programs, focused on the delivery of criteria set out in the National Safety and Quality Health Service (NSQHS) Standards - Standard 3.
The NAAN Committee will also provide a framework for collaborative health services research in antibiotic allergy and the formation of a registry for antibiotic allergy testing, to enable sites access to individual data for safety and monitoring purposes.
Key Projects:
1. International Network of Antibiotic Allergy Nations (iNAAN) Study - Penicillin Allergy Delabelling via Direct Oral Challenge
2. Clinical and consumer information and protocols
3. Antibiotic allergy advocacy and policy
Publications and naan resources
Published material from the NAAN committee is available via the link below
International Network of Antibiotic Allergy Nations (iNAAN)
iNAAN is an international study initially focusing on the collection of penicillin allergy assessment and direct oral challenge data in the inpatient setting.
The study utilises a purpose-built smartphone application (NAAN App) which integrates the published Antibiotic Allergy Assessment Tool and PEN-FAST clinical decision rule, enabling a point-of-care resultant risk-assessment and collection of penicillin allergy phenotypic data. The NAAN app also enables direct oral challenge data to be collected at the point-of-care. The NAAN app is automatically linked with a central iNAAN REDCap database hosted by BioGrid Australia.
The focus of this study is to collect penicillin allergy assessment and delabelling data to inform national guidelines, policy and AMS practice.
iNAAN has Austin Health Ethics (HREC) approval (HREC/78719/Austin-21) within Australia and local institutional review board (IRB) approval for participating international sites. iNAAN is supported by NAAN and CAAR, and is recruiting health services across Australia and internationally.
Further information: Please contact the iNAAN Project Manager, Ms. Elise Mitri - naan@austin.org.au